ENDEFR
Home › Czechia › ViaPharma s.r.o.

ViaPharma s.r.o.

Společnost s ručením omezeným · Praha, Czechia · LEI 315700GBBDD26W43GA43
LEI lapsed

Summary

ViaPharma s.r.o. is registered in Czechia and entered in the “Commercial Register (Obchodní rejstřík)” under number 14888742. Its legal form is Společnost s ručením omezeným – private limited company (Czechia). According to GLEIF, its ultimate parent is PHARMAX HOLDINGS LIMITED (Cyprus), which is also its direct parent. That group has 3 subsidiaries with LEIs in 4 countries, 1 of them in Czechia. The LEI was first issued on 20 Feb 2014 and the record was last updated on 27 Apr 2026. It has lapsed: renewal was due by 24 Feb 2026. AssetCensus found 2 data-quality notes for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The LEI has lapsed: it was due for renewal by 24 Feb 2026 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
  • The ultimate-parent relationship record was not renewed; it was last updated on 24 Feb 2026.

Company details

Legal formSpolečnost s ručením omezeným
private limited company (Czechia)
RegisterCommercial Register (Obchodní rejstřík) · Register website
Registration number14888742
Registration authorityMinistry of Justice
JurisdictionCzechia
Registered addressNa Florenci 2116/15, 110 00 Praha, Czechia
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)21 Feb 1991
LEI315700GBBDD26W43GA43
LEI statuslapsed
LEI first issued20 Feb 2014
LEI record last updated27 Apr 2026
Next LEI renewal24 Feb 2026
Corroboration of the LEI recordfully corroborated

Group membership

PHARMAX HOLDINGS LIMITED Cyprus ultimate parent
ViaPharma s.r.o. this entity
View the whole group: 3 subsidiaries in 4 countries

Relationship to the parent

Direct parentUltimate parent
ParentPHARMAX HOLDINGS LIMITEDPHARMAX HOLDINGS LIMITED
Accounting period1 Jan 2024 to 31 Dec 20241 Jan 2024 to 31 Dec 2024
Evidencesupporting documentssupporting documents
Corroborationsupplied by the entity onlysupplied by the entity only
Accounting standardIFRSIFRS
Consolidation percentage reported to GLEIF100.00%100.00%
Relationship start2 Feb 20222 Feb 2022
Recorded at GLEIF since2 Feb 20222 Feb 2022
Last updated24 Feb 202624 Feb 2026
Record statusnot renewednot renewed

Other subsidiaries of the same direct parent (4)